Transplantation Outcomes with Donor Hearts after Circulatory Death
Jacob N. Schroder(Duke University), David A. D’Alessandro(Chan Heart Rhythm Institute), Jason W. Smith(University of California, San Francisco), Koji Takeda(NewYork–Presbyterian Hospital), Tarek Absi(Vanderbilt University), David L. Joyce(Johns Hopkins University), Scott Silvestry(University of Arizona), Maryjane Farr(Columbia University), Si M. Pham(WinnMed), Yasuhiro Shudo(Stanford Health Care), Masashi Kai(Beth Israel Deaconess Medical Center), Hari R. Mallidi(Brigham and Women's Hospital), Tamer Attia(Cleveland Clinic), Karol Mudy(Abbott Northwestern Hospital), Andrew Shaffer(University of Minnesota Medical Center), John Dunning(Papworth Hospital NHS Foundation Trust), F. Esmailian(Cedars-Sinai Medical Center), Mohammed Quader(Virginia Commonwealth University), Mandeep R. Mehra(Harvard University), Arnar Geirsson(NewYork–Presbyterian Hospital), Amy G. Fiedler(Harvard University), Carmelo A. Milano(Duke University Hospital), Lucian Lozonschi(Tampa General Hospital), Mani A. Daneshmand(Emory University Hospital), Sarah Casalinova(Duke Medical Center), Ashish S. Shah(Vanderbilt University Medical Center), Joren C. Madsen(Massachusetts General Hospital), Michael M. Givertz(Brigham and Women's Hospital), Daniel J. Goldstein(Montefiore Medical Center), Christopher T. Salerno(University of Chicago Medical Center), Chetan B. Patel, Duc Thinh Pham(Northwestern University), Jonathan M. Philpott(Sentara Norfolk General Hospital), John Um(University of Nebraska Medical Center), Adam D. DeVore(Duke University), Ben C. Sun(Minneapolis Heart Institute Foundation), Benjamin S. Bryner(Northwestern University), Bassam Shukrallah(The University of Texas MD Anderson Cancer Center), Gregory S. Couper(Tufts Medical Center), Victor Pretorius(University of California San Diego)
Cited by 328
Related Papers
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Medical Therapy for Heart Failure With Reduced Ejection Fraction
|Journal of the American College of Cardiology|2018|1.3k
Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure
|New England Journal of Medicine|2000|908
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
|American Journal of Transplantation|2020|837